Prostate Cancer - Results from #100

Comparison of Outcome Endpoints in Intermediate- and High-Risk Prostate Cancer After Combined-Modality Radiotherapy - Beyond the Abstract February 12, 2020

Germline Genetic Testing in Advanced Prostate Cancer; Practices and Barriers: Survey Results from the Germline Genetics Working Group of the Prostate Cancer Clinical Trials Consortium - Beyond the Abstract February 7, 2020

Metastatic Castration-Sensitive Prostate Cancer: Abiraterone, Docetaxel, or... - Beyond the Abstract January 24, 2020

New Frontiers in Prostate Cancer Imaging: Clinical Utility of Prostate-Specific Membrane Antigen Positron Emission Tomography - Beyond the Abstract January 22, 2020

Health-Related Quality of Life After Apalutamide Treatment in Patients with Metastatic Castration-Sensitive Prostate Cancer (TITAN): a Randomized, Placebo-Controlled, Phase 3 Study - Beyond the Abstract January 20, 2020

Impact of Progression at Baseline and On-Treatment Progression Events in Three Large Prostate Cancer Trials - Beyond the Abstract January 10, 2020

Changes in Prostate Cancer Presentation Following the 2012 USPSTF Screening Statement: Observational Study in a Multispecialty Group Practice - Beyond the Abstract January 9, 2020

PSA Doubling Time and Absolute PSA Predict Metastasis-free Survival in Men With Biochemically Recurrent Prostate Cancer after Radical Prostatectomy - Beyond the Abstract December 20, 2019

Promise of PET Imaging in Prostate Cancer, Improvement or Waste of Money? With Great Power Comes Great Responsibility - Beyond the Abstract December 18, 2019

Surgical versus Medical Castration for Metastatic Prostate Cancer: Use and Overall Survival in a National Cohort - Beyond the Abstract December 18, 2019

Effect of a Smoking Cessation Program on Sexual Function Recovery Following Robotic Prostatectomy at Kaiser Permanente Southern California - Beyond the Abstract December 10, 2019

Questioning the Status Quo: Should Gleason Grade Group 1 Prostate Cancer be Considered A “Negative Core” in Pre-Radical Prostatectomy Risk Nomograms? An International Multicenter Analysis – Beyond the Abstract December 9, 2019

Radiotherapy in Metastatic Castration Resistant Prostate Cancer Patients with Oligo-Progression during Abiraterone-Enzalutamide Treatment: A Mono-Institutional Experience - Beyond the Abstract December 9, 2019

Androgen Deprivation Therapy in Men with Node-positive Prostate Cancer Treated with Post-operative Radiotherapy - Beyond the Abstract December 3, 2019

Multiparametric Magnetic Resonance Imaging for the Detection of Clinically Significant Prostate Cancer: What Urologists Need to Know. Part 1: Acquisition - Beyond the Abstract November 14, 2019

Magnetic Resonance Imaging-targeted Biopsy Versus Systematic Biopsy in the Detection of Prostate Cancer: A Systematic Review and Meta-Analysis – Beyond the Abstract October 31, 2019

Temporal Changes in Survival in Men with de Novo Metastatic Prostate Cancer: Nationwide Population-based Study - Beyond the Abstract October 30, 2019

Prostate-Specific Membrane Antigen Ligand Positron-Emission Tomography in Men with Nonmetastatic Castration-Resistant Prostate Cancer - Beyond the Abstract October 18, 2019

The Impact of Diurnal Variation of PSA on Timing of Measurement in Prostate Biopsy - Beyond the Abstract October 14, 2019

Fatigue, Quality of Life and Metabolic Changes in Men Treated with First-line Enzalutamide versus Abiraterone Plus Prednisolone for Metastatic Castration-resistant Prostate Cancer (HEAT): A Randomised Trial Protocol - Beyond the Abstract October 10, 2019

Page 6 of 42